These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2825993)

  • 1. Phase II trial of mitoxantrone as first-line chemotherapy for extensive small cell lung cancer.
    Malik ST; Rayner H; Fletcher J; Slevin ML
    Cancer Treat Rep; 1987 Dec; 71(12):1291-2. PubMed ID: 2825993
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitoxantrone for treatment of patients with refractory small cell carcinoma of the lung: a Southwest Oncology Group Study.
    Von Hoff DD; Chen T; Clark GM; Callahan SK; Livingston R
    Cancer Treat Rep; 1983 Apr; 67(4):403-4. PubMed ID: 6303588
    [No Abstract]   [Full Text] [Related]  

  • 3. Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD; Morrissey LH; Scullin DC; Houston GA; Prasthofer EF; Gray JR; Burris HA; Greco FA
    Cancer; 2002 May; 94(9):2426-33. PubMed ID: 12033195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II clinical trial with bisantrene in patients with advanced refractory small cell lung cancer.
    Myers JW; Von Hoff DD; Clark GM; Coltman CA
    Cancer Treat Rep; 1984 Jun; 68(6):927-8. PubMed ID: 6329511
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II trial of 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
    Joss RA; Obrecht JP; Alberto P; Siegenthaler P; VanHelvoirt A; Cavalli F
    Cancer Treat Rep; 1984 Mar; 68(3):563-4. PubMed ID: 6322990
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial.
    Kramer BS; Birch R; Gockerman JP; Greco A; Prestridge K
    Cancer Treat Rep; 1986 Jun; 70(6):803-4. PubMed ID: 3015404
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II trial of vindesine in patients with small cell lung carcinoma.
    Natale RB; Gralla RJ; Wittes RE
    Cancer Treat Rep; 1981; 65(1-2):129-31. PubMed ID: 6261946
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II trial of AMSA in patients with refractory small cell carcinoma of the lung.
    Fuks JZ; Van Echo DA; Aisner J; Von Hoff D; Wiernik PH
    Cancer Treat Rep; 1981; 65(1-2):133-4. PubMed ID: 6261947
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II study of vinblastine in small cell carcinoma of the lung.
    Sörenson S; Osterlind K; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1983 Mar; 67(3):293-5. PubMed ID: 6299548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of mitoguazone in patients with relapsed small cell carcinoma of the lung.
    Scher H; Chapman R; Kelsen D; Gralla R; Wittes R
    Cancer Treat Rep; 1984 Mar; 68(3):561-2. PubMed ID: 6322989
    [No Abstract]   [Full Text] [Related]  

  • 11. A phase II trial of m-AMSA in patients with small-cell lung cancer.
    Natale RB; Gralla RJ; Wittes RE
    Cancer Clin Trials; 1981; 4(4):393-5. PubMed ID: 6274533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of small cell lung cancer with 6-mercaptopurine: a phase II study.
    Hansen SW; Skovsgaard T; Sørensen JB
    Cancer Treat Rep; 1985 May; 69(5):555. PubMed ID: 2988775
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II evaluation of amsacrine in small cell lung cancer: a Southeastern Cancer Study Group trial.
    Kramer BS; Birch R; Einhorn L; Greco A
    Cancer Treat Rep; 1985 Mar; 69(3):333-4. PubMed ID: 2983895
    [No Abstract]   [Full Text] [Related]  

  • 14. [A phase II study of vindesine for pretreated non-small cell lung cancer].
    Shimizu E; Nakamura Y; Yamasaki K; Kimura K; Inoue I; Nakahira S; Kawahito K; Tani K; Sone S; Yamashita T
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2532-6. PubMed ID: 3039921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topotecan and etoposide as first-line therapy for extensive disease small cell lung cancer: a phase II trial of a platinum-free regimen.
    Reck M; Groth G; Buchholz E; Goetz E; Gatzemeier U; Manegold C
    Lung Cancer; 2005 Jun; 48(3):409-13. PubMed ID: 15893010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of cisplatin in small cell carcinoma of the lung.
    Levenson RM; Ihde DC; Huberman MS; Cohen MH; Bunn PA; Minna JD
    Cancer Treat Rep; 1981; 65(9-10):905-7. PubMed ID: 6268297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of new drugs in small cell lung cancer: phase II agents first?
    Aisner J
    Cancer Treat Rep; 1987 Dec; 71(12):1131-3. PubMed ID: 2825989
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytarabine: an inactive drug for extensive-stage small cell lung cancer.
    Stuart-Harris R; Bishop J; Raghavan D; Gianoutsos P; Lee J; Hillcoat B; Fox R
    Cancer Treat Rep; 1986 Feb; 70(2):303-4. PubMed ID: 3004728
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II evaluation of triazinate in patients with metastatic lung cancer.
    Creagan ET; Eagan RT; Fleming TR; Frytak S; Ingle JN; Kvols LK; Nichols WC
    Cancer Treat Rep; 1980; 64(10-11):1057-9. PubMed ID: 6257389
    [No Abstract]   [Full Text] [Related]  

  • 20. [A phase II study of intravenous VP-16-213 in small cell and non-small cell carcinoma of the lung].
    Konno K; Nagahama F; Nakai Y; Nakabayashi T; Hiraga Y; Takebe K; Tamura M; Oizumi K; Sato M; Ito T
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):931-7. PubMed ID: 3008671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.